Clinical Trial Update: A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the long-term safety and tolerability of oral lacosamide in pediatric epilepsy patients who completed prior lacosamide trials; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2025-08-28